Amerikanische Gesellschaft für Hirudotherapie

Transcriptomics and differential gene expression in Helobdella: contrasting feeding and fasting modes

Transcriptomics study published in Ecology and Evolution (2019)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomik & ProteomikKhan MS · Ecology and evolution, 2019

Abstract

The medicinal utility of leeches has been demonstrated through decades of use in modern hospital settings, mainly as relievers of venous congestion following flap or digit replantation surgery. In the present study, we sequence and annotate (through BLAST- and Gene Ontology-based approaches) the salivary transcriptome of the nonblood feeding hirudinid Whitmania pigra and assess the differential gene expression of anticoagulation factors (through both quantitative real-time PCR [qRT-PCR] and in silico-based methods) during feeding and fasting conditions. This was done in order to evince the diversity of putative anticoagulation factors, as well as estimate the levels of upregulation of genes immediately after feeding. In total, we found sequences with demonstrated orthology (via both phylogenetic analyses and BLAST-based approaches) to seven different proteins that have previously been linked to anticoagulatory capabilities-eglin C, bdellin, granulin, guamerin, hyaluronidase, destabilase I, and lipocalin. All of these were recovered from leeches both in the fasting and in the feeding conditions, but all show signs of upregulation in the feeding leeches. Interestingly, our RNA-seq effort, coupled with a hypergeometric test, indicated that the differentially expressed genes were disproportionately involved in three main immunological pathways (endocytosis, peroxisome regulation, and lysosome regulation). The results and implications of the finding of anticoagulants in this nonblood feeding leech and the putative upregulation of anticoagulation factors after feeding are briefly discussed in an evolutionary context.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Zusammenfassung

Compares fed vs fasted Helobdella transcriptomes, identifying genes upregulated during digestion of blood meal — informs leech metabolic biology.

Warum dies für die Hirudotherapie relevant ist

This study sequenced and annotated the salivary transcriptome of the nonblood-feeding hirudinid leech Whitmania pigra and assessed differential expression of anticoagulation-associated genes during feeding versus fasting using RNA-seq and qRT-PCR. It recovered sequences with orthology to seven known anticoagulant or anticoagulant-linked proteins (eglin C, bdellin, granulin, guamerin, hyaluronidase, destabilase I, lipocalin), all upregulated in feeding animals, and found that differentially expressed genes were enriched in immunological pathways (endocytosis, peroxisome regulation, lysosome regulation). This is relevant to ASH because it expands understanding of the diversity and regulation of putative anticoagulant factors within the leech salivary repertoire, even in a non-sanguivorous species, offering evolutionary context for the leech secretome. The study is purely molecular/transcriptomic with no functional protein assays, clinical data, or direct hirudotherapy application; Whitmania pigra is not a standard medicinal leech.

Zitation

Transcriptomics and differential gene expression in Helobdella: contrasting feeding and fasting modes.

Khan MS · Ecology and evolution, 2019

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.